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Two-pore domain K+ (K2P) channels are thought to underlie background K+ conductance
in many cell types. The Trek subfamily of K2P channels consists of three members,
Trek1/Kcnk2, Trek2/Kcnk10, and Traak/Kcnk4, all three of which are expressed in the rodent
CNS. Constitutive ablation of the Trek1 gene in mice correlates with enhanced sensitivity
to ischemia and epilepsy, decreased sensitivity to the effects of inhaled anesthetics,
increased sensitivity to thermal and mechanical pain, and resistance to depression. While
the distribution of Trek2 mRNA in the CNS is broad, little is known about the relevance
of this Trek family member to neurobiology and behavior. Here, we probed the effect of
constitutive Trek2 ablation, as well as the simultaneous constitutive ablation of all three
Trek family genes, in paradigms that assess motor activity, coordination, anxiety-related
behavior, learning and memory, and drug-induced reward-related behavior. No differences
were observed between Trek2−/− and Trek1/2/Traak−/− mice in coordination or total
distance traveled in an open-field. A gender-dependent impact of Trek ablation on
open-field anxiety-related behavior was observed, as female but not male Trek2−/− and
Trek1/2/Traak−/− mice spent more time in, and made a greater number of entries into, the
center of the open-field than wild-type counterparts. Further evaluation of anxiety-related
behavior in the elevated plus maze and light/dark box, however, did not reveal a significant
influence of genotype on performance for either gender. Furthermore, Trek−/− mice
behaved normally in tests of learning and memory, including contextual fear conditioning
and novel object recognition, and with respect to opioid-induced motor stimulation and
conditioned place preference (CPP). Collectively, these data argue that despite their broad
distribution in the CNS, Trek channels exert a minimal influence on a wide-range of
behaviors.
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INTRODUCTION
Two-pore domain K+ (K2P) channels are thought to underlie
the background K+ conductance in many cell types (Enyedi and
Czirjak, 2010). The K2P channel family is diverse, with six sub-
families containing members that differ primarily in terms of
biophysical properties and regulation (Enyedi and Czirjak, 2010).
The Trek subfamily of K2P channels consists of three members—
Trek1/Kcnk2, Trek2/Kcnk10, and the more distantly-related mem-
ber, Traak/Kcnk4. Trek1 and Trek2 channel activity is regulated
by a diverse set of stimuli including arachidonic acid (Patel et al.,
1998; Lesage et al., 2000; Maingret et al., 2000), membrane stretch
(Patel et al., 1998; Bang et al., 2000; Lesage et al., 2000), intracel-
lular acidification (Maingret et al., 1999; Lesage et al., 2000; Kim
et al., 2001), and heat (Maingret et al., 2000; Kang et al., 2005).
Additionally, both Trek1 and Trek2 channels are inhibited by pro-
tein kinase A (PKA) and protein kinase C (PKC) phosphorylation,
which couples these channels to Gs, Gi/o, and Gq G protein sig-
naling cascades (Fink et al., 1996; Patel et al., 1998; Lesage et al.,
2000; Maingret et al., 2000; Bockenhauer et al., 2001; Murbartian
et al., 2005).
In situ hybridization revealed a broad distribution of Trek1
in the rat CNS (Talley et al., 2001; Gu et al., 2002), and genetic
ablation of Trek1 correlates with multiple neurophysiological and
neurobehavioral phenotypes. Trek1−/− mice are more sensitive
to ischemia and epilepsy, show lower sensitivity to the effects of
inhaled anesthetics, and display an increased sensitivity to ther-
mal and mechanical pain (Heurteaux et al., 2004; Alloui et al.,
2006; Noel et al., 2009). Trek1−/− mice also exhibit a depression-
resistant phenotype, suggesting that Trek1-containing channels
are a potential downstream target of selective serotonin reuptake
inhibitors (SSRIs). Indeed, these drugs had no effect on Trek1−/−
mice (Heurteaux et al., 2006). Accordingly, Trek1 represents a
potential target for novel therapeutic strategies to combat depres-
sion (Perlis et al., 2008; Liou et al., 2009; Mazella et al., 2010;
Moha ou Maati et al., 2011; Moha Ou Maati et al., 2012).
Compared with Trek1, relatively little is known about the
neurobiological relevance of Trek2. An early study described a
limited CNS distribution of Trek2 (Talley et al., 2001). Other
evidence, however, including results from human tissue PCR,
in situ hybridization from zebrafish, and rat in situ hybridiza-
tion data suggest that Trek2 is expressed broadly throughout the
CNS (Medhurst et al., 2001; Gu et al., 2002; Gierten et al., 2012).
Moreover, we reported recently using a cDNA panel that Trek2
mRNA is expressed in most regions of the mouse brain (Mirkovic
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and Wickman, 2011). These observations suggest that Trek2 may
make a broad and significant contribution to neurophysiology
and behavior.
While RNAi-dependent knockdown of Trek2 in the entorhinal
cortex was shown to disrupt spatial memory (Deng et al., 2009),
data concerning the neurobehavioral relevance of Trek2 are scant.
The recent development of mice lacking Trek2 (Trek2−/−) and all
three members of the Trek channel family (Trek1/2/Traak−/−),
however, permit rigorous testing of the role of Trek channels, and
Trek2-containing channels in particular, in behavior (Heurteaux
et al., 2004; Guyon et al., 2009). In this study, we probe the conse-
quences of constitutive Trek gene ablation in mice, in paradigms
that assess motor activity, coordination, anxiety-related behav-
ior, learning and memory, and drug-induced reward-related
behavior.
MATERIALS AND METHODS
EXPERIMENTAL SUBJECTS
All animal use was approved by the University of Minnesota
Institutional Animal Care and Use Committee and carried out in
accordance with National Institutes of Health guidelines. All mice
used in this study were bred on-site, housed in same-sex groups
of 2–5 after weaning, and provided with food and water ad libi-
tum. Mice were kept on a 12 h light/dark cycle, with lights on
between 0700 and 1900. All tests were performed between 0900
and 1600. Mice lacking Trek2 (Trek2−/−) and mice lacking Trek1,
Trek2, and Traak (Trek1/2/Traak−/−) were generated as described
(Heurteaux et al., 2004; Guyon et al., 2009). Null mutations were
backcrossed against the C57BL/6J inbred strain for 10+ gener-
ations prior to establishing the breeding cages used to generate
subjects for this study. Both male and female mice (5–10 weeks)
were evaluated in all behavioral tests. No more than three distinct
behavioral tests were performed on any single animal, and in no
instance were animals evaluated in any test after completing the
morphine-induced motor activity, conditioned place preference
(CPP) studies, or the contextual fear conditioning test.
LOCOMOTOR ACTIVITY
One day prior to locomotor activity assessments, mice were habit-
uated to handling (5min) and testing room (60min). On the first
day of testing, mice were placed in open-field activity chambers
(ENV-515; Med Associates, Inc.; St. Albans, VT), housed within
sound-attenuating cubicles for 60min. The open-field was illu-
minated with 28V DC/100mA house lights (ENV-215M; Med
Associates, Inc.) during testing. Total distance traveled, thigmo-
taxis, and time/entries into the central area of the open-field
were recorded using Open Field Activity Software package v. 4.0
(Med Associates, Inc.). For the morphine-induced motor activity
study, total distance traveled was measured for 60min, begin-
ning 10min after an intraperitoneal (i.p.) injection of morphine
(Sigma; St Louis, MO). Each mouse received all morphine doses,
with three rest days between injections.
ROTAROD
Motor coordination was assessed using an accelerating rotarod
(IITC Life Sciences; Woodland Hills, CA), as described (Anderson
et al., 2010). Briefly, mice were acclimated to the testing room 1h
prior to evaluation. Each subject was given two trials to acclimate
to the task, followed by 6-test trial. Animals were allowed a min-
imum of 15min to rest between trials, followed by a 2 h break
after trial 4. After placement of the subject on the rod, the rod
was accelerated from 4 to 27 rpm over a 5min period. Latency to
fall was recorded when a subject fell from the rod, or made 2 full
revolutions while clinging to the drum.
ELEVATED PLUS MAZE
Anxiety-related behavior was measured using the elevated plus
maze, as described (Pravetoni andWickman, 2008). In brief, mice
were acclimated to the testing room 1h prior to evaluation. The
maze consisted of two open and two closed arms, as well as an
exposed center panel, elevated 52 cm off the floor of the testing
room (Columbus Instruments, Inc.; Columbus, OH). Testing was
conducted under standard room lighting conditions. Each trial
began with the placement of the mouse in the maze center, facing
a closed arm; subsequent activity was recorded by video camera
for 5min. The time spent by each mouse in the open and closed
arms was scored manually by two investigators blind to subject
genotype. Time spent in the EPM center was not included as time
in either open or closed arms.
LIGHT/DARK BOX
The light/dark test was performed in a modified two-
compartment mouse CPP chamber (Env-3013-2; Med Associates,
Inc.) housed in a sound-attenuating cubicle. Flooring was nor-
malized in both compartments using plexiglass inserts. The over-
head light was turned off in the black chamber (dark), while
the white (light) chamber was illuminated by a 28 V DC/100mA
light bulb (ENV-221M; Med Associates, Inc.) connected to a 3-
channel light control unit (ENV-226B; Med Associates, Inc.) set
at intensity level 10. Mice were acclimated to the testing room for
30min before testing. The mouse was placed in the center of the
black chamber and allowed full access to both compartments after
a 5 s delay. Time spent and distance traveled in both compart-
ments was recorded during a 10min trial using Med-PC software
(Med Associates, Inc.).
CONTEXTUAL FEAR CONDITIONING
Contextual fear conditioning was conducted in 30.5 × 24.1 ×
21.0 cm conditioning chambers (VFC_008; Med Associates, Inc.),
housed in a sound-attenuating cubicle, utilizing steel bar floor-
ing connected to a shock generator. The chamber was illuminated
using a combination infrared and visual overhead light box (NIR-
100; Med Associates, Inc.). Mice were allowed to acclimate to
the testing room for 30min prior to testing. Training consisted
of 120 s baseline exposure followed by three conditioning trials.
Each conditioning trial consisted of a 20 s light cue (ENV-229M;
Med Associates, Inc.), a 20 s latency period, and a 2 s shock
(0.7mA), with an inter-trial interval of 60 s. A 5min test session
was conducted 24 h later, where time spent freezing and number
of freezing episodes were recorded using “Video freeze” software
(Med Associates, Inc.).
NOVEL OBJECT RECOGNITION
The novel object recognition study was performed using open-
field environments (ENV-022MD; Med Associates, Inc.), housed
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within sound-attenuating cubicles, and illuminated with 28 V
DC/100mA house lights (ENV-215M; Med Associates, Inc.).
On Day 1, mice were handled and habituated to the open
field environment for 60min. On Day 2, mice were evalu-
ated over four sessions, separated by 10min breaks, during
which subjects were returned to their home cages. In Session
1, animals were allowed to explore the open-field environment
for 30min. In Sessions 2 and 3, mice were re-introduced to
the open-field environment for 10min, and in both sessions
the environments contained two identical objects (familiar). In
Session 4, mice were re-introduced to the open-field environ-
ment for 5min, now containing one familiar and one novel
object. Session 4 was videotaped and the time subjects spent
interacting with each object was recorded manually. A sub-
ject was considered to be interacting with an object if its nose
was directed toward (and within 2 cm of) the object. Objects
used in this study were a single red Duplo (The LEGO Group;
Enfield, CT) and a blue cap from a 50mL conical tube. Objects
were counter-balanced to account for any object preference
effects.
CONDITIONED PLACE PREFERENCE
CPP was performed in two-compartment mouse CPP cham-
bers (Env-3013-2; Med Associates, Inc.), housed within sound-
attenuating cubicles. One compartment contained white walls
and a mesh floor, and the other contained black walls and a rod
floor. The overhead light was identical in both chambers: a 28 V
DC/100mA light (ENV-221M; Med Associates, Inc.) connected
to a 3-channel light control unit (ENV-226B; Med Associates,
Inc.) set at intensity level 8. All subjects were acclimated to han-
dling (5min) and the testing room (1 h) for 2–3 d prior to
beginning the 5-day test. OnDay 1, mice were placed in the cham-
ber for 15min with the door separating compartments open;
time spent in each compartment was recorded. Subjects spend-
ing more than 65% of their time in either compartment on Day
1 were excluded from the study. On Days 2–4, mice were sub-
jected to two 20-min conditioning sessions, one in the morning
(0900–1100) and one in the afternoon (1400–1600). In the morn-
ing session, mice were given a subcutaneous (s.c.) saline injection
and confined to the compartment that was preferred on Day 1.
In the afternoon sessions, mice were given s.c. morphine and
confined to the opposite compartment. On Day 5, mice were
placed in the chamber for 15min with the door separating the
compartments open; time spent in each compartment was then
recorded during a 15min test session using Med-PC software.
The change in time spent on the drug-paired side as measured
on Day 1 and Day 5 (Day 5—Day 1) was taken as the measure of
morphine-induced CPP.
STATISTICAL ANALYSIS
Data are expressed throughout as mean ± SEM and were ana-
lyzed using Sigma Plot 11.0 (Systat Software Inc.; Chicago, IL) or
Prism v. 11 (GraphPad Software Inc.; La Jolla, CA). The potential
impact of gender on performance in each task was assessed with
two-way ANOVA for all tasks except rotarod, morphine-induced
locomotor activation, and CPP, where a 3-way ANOVA was used.
If the results of statistical analysis revealed no significant impact
of gender on task performance, data from male and female sub-
jects were pooled to increase the power of the analysis. Open field
activity, elevated plus maze, light/dark box, contextual fear con-
ditioning, and novel object recognition data were analyzed using
one-way ANOVA; the Newman Keuls post hoc test was used when
a significant interaction was found. For rotarod and morphine-
induced motor activity data, a two-way ANOVA with repeated
measures was used. Data from the morphine-induced CPP study
was analyzed using a standard two-way ANOVA. Differences were
considered significant if P < 0.05.
RESULTS
The main goal of this study was to evaluate wild-type C57BL/6J
and congenic Trek2−/− mice in tests of motor activity, coordina-
tion, anxiety, learning and memory, and reward-related behavior.
Congenic mice lacking all three members of the Trek sub-
family (Trek1/2/Traak−/− mice) were evaluated in parallel, as
up-regulation of Trek1 and/or Traak might compensate for the
loss of Trek2 and suppress neurobehavioral phenotypes. Prior
to testing, we profiled Trek2−/− and Trek1/2/Traak−/− mice
for gross deficiencies in sensory perception that might influ-
ence performance in the chosen behavioral tests. Trek2−/− and
Trek1/2/Traak−/− mice were indistinguishable from wild-type
counterparts by all visual criteria, and they responded nor-
mally, without excessive vocalization, to gentle prodding and
handling. No genotype-dependent differences in body weight
were observed (not shown). Following acclimation to a dark
room, Trek2−/− and Trek1/2/Traak−/− mice exhibited a nor-
mal pupil response (constriction) to a bright light. Trek2−/−
andTrek1/2/Traak−/− mice also exhibited normal forepaw exten-
sion upon lowering to their home cage or benchtop, indica-
tive of intact vision and normal depth perception. Trek2−/−
and Trek1/2/Traak−/− mice exhibited normal responses to sud-
den sounds (clapping), arguing against gross deficits in hear-
ing. Thus, no obvious developmental abnormalities, or deficits
in touch, vision, or hearing, were evident in Trek2−/− and
Trek1/2/Traak−/− mice.
MOTOR ACTIVITY AND COORDINATION
Wild-type,Trek2−/− andTrek1/2/Traak−/− mice weremonitored
for 60min in open-field activity chambers for distance traveled
and position within the field. Because we observed an influ-
ence of gender on time spent in and entries into the center of
the open-field, all open-field activity data for male and female
subjects were analyzed separately. No genotype-dependent dif-
ferences were observed in male or female mice with respect to
total distance traveled (Figure 1A) or velocity (Figure 1B). In
malemice, no genotype-dependent differences were detected with
respect to thigmotaxis (calculated as the ratio of distance traveled
in the field periphery to total distance traveled), time spent in
the center of the open-field, or number of entries into the cen-
ter of the open-field (Figures 1C-E). In female mice, however,
both Trek2−/− and Trek1/2/Traak−/− mice showed less thigmo-
taxis (Figure 1C). Female Trek2−/− and Trek1/2/Traak−/− mice
also spent more time than wild-type controls in the field cen-
ter (Figure 1D), and exhibited significantly more entries into the
center as compared to wild-type female controls (Figure 1E),
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FIGURE 1 | Motor activity and coordination in mice lacking Trek
channels. Open-field activity was measured in wild-type (WT, white),
Trek2−/− (T2, gray), and Trek1/2/Traak−/− (TTT, black) mice during a
60min test session (n = 8–12 per group). (A) Total distance traveled
during the 60min session. No genotype-dependent differences were
observed between male [F(2, 29) = 2.3, P = 0.12] or female [F(2, 30) = 1.9,
P = 0.17] Trek2−/− , Trek1/2/Traak−/− , and wild-type mice. (B) Velocity
during open-field activity; no genotype-dependent differences were
observed between male [F(2, 29) = 2.1, P = 0.14] or female [F(2, 30) = 0.3,
P = 0.78] Trek2−/− , Trek1/2/Traak−/− , and wild-type mice.
(C) Thigmotaxis scores (distance traveled in periphery/total distance
traveled); no genotype-dependent differences were observed in male
animals [F(2, 29) = 2.2, P = 0.13], whereas both Trek2−/− and
Trek1/2/Traak−/− females traveled less distance in the field periphery
than wild-type controls [F(2, 30) = 11.0, P < 0.001]. (D) Time spent in the
center of the open-field; a mild genotype-dependent difference was
observed for male animals [F(2, 29) = 3.4, P < 0.05], though post hoc
pairwise comparisons did not reveal a difference between Trek2−/− ,
Trek1/2/Traak−/− , and wild-type controls. Trek2−/− and Trek1/2/Traak−/−
females spent significantly more time in the center than wild-type
controls [F(2, 30) = 18.7, P < 0.0001]. (E) Number of entries into center of
the open-field; no genotype-dependent differences were observed in male
animals [F(2, 29) = 2.1, P = 0.14], whereas both Trek2−/− and
Trek1/2/Traak−/− females made more entries into the center than
wild-type controls [F(2, 30) = 7.7, P < 0.01]. (F) Rotarod performance of
wild-type, Trek2−/− , and Trek1/2/Traak−/− mice, measured over six
separate trials (n = 11–18 per group). A main effect of trial number was
observed [F(5, 228) = 8.80, P < 0.001]; within-genotype, pair-wise
comparisons are not shown on the plot. A main effect of genotype was
not detected [F(2, 228) = 3.0, P = 0.06], nor was there a significant
interaction between trial and genotype [F(10, 228) = 0.8, P = 0.62].
Symbols: ∗,∗∗ ,∗∗∗ P < 0.05, 0.01, and 0.001, respectively, vs. wild-type.
behaviors consistent with lower anxiety-related behavior (Simon
et al., 1994).
Motor coordination was evaluated in wild-type, Trek2−/−,
and Trek1/2/Traak−/− mice using an accelerating rotarod test
as described (Anderson et al., 2010). No effect of gender was
observed in this task [F(1, 263) = 2.9, P = 0.09]; as such male
and female data were pooled. No genotype-dependent differences
were observed with respect to ability of the mice to learn the task,
learning rate, or peak performance (Figure 1F).
ANXIETY-RELATED BEHAVIOR
While rotarod and open-field activity data indicated that
Trek2−/− and Trek1/2/Traak−/− mice do not exhibit gross defi-
ciencies in motor activity or coordination, the reduced thigmo-
taxis observed in female Trek2−/− and Trek1/2/Traak−/− mice
argued that Trek channels may influence anxiety-related behav-
ior. To gain additional insight into anxiety-related behavior in
Trek2−/− and Trek1/2/Traak−/− mice, we next examined per-
formance in an elevated plus maze, an established measure
of anxiety-related behavior (Lister, 1987). While Trek2−/− and
Trek1/2/Traak−/− mice tended to spend more time in the open
arms (Figure 2A), and made more entries into the open arms
of the maze (Figure 2B), differences were not significant, for
either gender. Similarly, no genotype-dependent differences were
observed in either male or female mice in terms of the time spent
in closed arms (Figure 2C) or number of entries into the closed
arms (Figure 2D).
We also tested animals in the light/dark box, an alternative
measure of anxiety-related behavior (Bourin and Hascoet, 2003).
In this task, animals are placed in a two-compartment chamber,
one dark and the other brightly illuminated. Increased time spent
in the light chamber is consistent with reduced anxiety-related
behavior (Costall et al., 1989). As an influence of gender was pre-
viously observed in the open-field test, we again analyzed data
from male and female subjects separately. Total time spent in the
light compartment did not differ between genotypes in male or
female mice (Figure 3A). Moreover, no gender or genotype differ-
ences were observed with respect to total distance traveled during
the 10-min trial (not shown) or distance traveled in the light
compartment (Figure 3B).
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FIGURE 2 | Elevated plus maze performance in mice lacking Trek
channels. Wild-type (WT, white), Trek2−/− (T2, gray), and Trek1/2/Traak−/−
(TTT, black) mice were evaluated in a 5min (300 s) EPM test (n = 8–19 per
group). No genotype-dependent differences were observed with respect to
male or female mice in time spent in (A) [male: F(2, 40) = 0.8, P = 0.46;
female: F(2, 49) = 1.4, P = 0.25] or number of entries into (B) [male:
F(2, 40) = 1.9, P = 0.16; female: F(2, 49) = 0.9, P = 0.41] the open arms.
Likewise, no significant differences were observed with respect to
genotype in time spent in (C) [male: F(2, 40) = 0.5, P = 0.59; female:
F(2, 49) = 0.1, P = 0.93] or number of entries into (D) [male: F(2, 40) = 0.03,
P = 0.97; female: F(2, 48) = 0.3, P = 0.77] the closed arms.
LEARNING AND MEMORY
To assess the learning and memory ability of Trek2−/− and
Trek1/2/Traak−/− mice, we first tested animals in a contextual
fear conditioning task. This 2 d test of Pavlovian learning involves
the association of a painful stimulus (foot shock) with an envi-
ronment (Rudy et al., 2004). The first session included three con-
ditioning trials separate by 60 s, each consisting of a 2 s (0.7mA)
shock delivered after presentation of a 20 s light cue. The test day
consisted of a 5min re-exposure to the training environment and
evaluation of freezing behavior. No effect of gender was observed
in total time spent freezing [F(1, 29) = 2.8, P = 0.11] or in the
number of freezing episodes [F(1, 29) = 0.1, P = 0.72]; as such,
data from male and female subjects were pooled. No genotype-
dependent differences were observed in total time spent freezing
(Figure 4A) or in the number of freezing episodes (Figure 4B).
We next tested the effect of Trek ablation in the novel object
recognition task, which has been used to assess working memory,
anxiety, and preference for novelty in rodents (Dere et al., 2007).
The task requires an animal to recognize and recall prior experi-
ence with a familiar object, and discriminate that object from a
novel object. In our paradigm, mice were exposed to the open-
field chamber for 60min on the day prior to testing. On test day,
mice were re-introduced to the open-field chamber for 30min,
then again in two consecutive 10min sessions incorporating an
object (familiar), and finally in a 5-min test session where both
the familiar object and a novel object were present in the field.
The time spent exploring both objects were recorded during the
FIGURE 3 | Light/dark box behavior in mice lacking Trek channels.
Wild-type (WT, white), Trek2−/− (T2, gray), and Trek1/2/Traak−/−
(TTT, black) mice were evaluated in a 10min (600 s) light/dark box test
(n = 5–12 per group). (A) Time spent in the light compartment; no
genotype-dependent differences were observed for male [F(2, 22) = 2.7,
P = 0.09] or female [F(2, 25) = 1.0, P = 0.38] mice. (B) Distance traveled in
the light compartment; no genotype-dependent differences were observed
in male [F(2, 22) = 1.7, P = 0.21] or female [F(2, 25) = 0.2, P = 0.82] mice.
FIGURE 4 | Contextual fear conditioning in mice lacking Trek channels.
Wild-type (WT, white), Trek2−/− (T2, gray), and Trek1/2/Traak−/− (TTT,
black) mice were evaluated in 5min (300 s) contextual fear conditioning test
(n = 9–14 per group). (A) Time spent freezing; no genotype-dependent
differences were observed with respect to time spent freezing
[F(2, 34) = 2.4, P = 0.11]. (B) Freezing episodes; no genotype-dependent
differences were observed with respect to number of freezing episodes
[F(2, 34) = 1.4, P = 0.25].
test session. No effect of gender was observed for any parameter
analyzed (time exploring novel object, F(1, 19) = 0.4, P = 0.55;
time exploring familiar object, F(1, 19) = 0.8, P = 0.39; total time
exploring objects, F(1, 19) = 0.1, P = 0.78; discrimination ratio,
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F(1, 19) = 2.3, P = 0.14), and as such, data from male and female
subjects were pooled. The total time spent exploring both the
familiar (Figure 5A) and novel (Figure 5B) objects during the test
session were not different across genotypes, nor was the total time
spent exploring both objects (Figure 5C). And, while all geno-
types showed a preference for the novel object over the familiar,
no differences were observed with respect to genotype in this
regard (Figure 5D).
REWARD-RELATED BEHAVIOR
Normal opioid-induced motor stimulation and CPP require acti-
vation of mu opioid receptors in midbrain structures, including
the ventral tegmental area (Bozarth and Wise, 1986; Bozarth,
1987; Kalivas and Duffy, 1987; Latimer et al., 1987). Mu opioid
receptors are metabotropic (G protein-coupled) receptors linked
to the Gi/o subclass of G proteins. Previous studies have indi-
cated that both Trek1 and Trek2 can be activated by GPCRs linked
to Gi/o G proteins (Fink et al., 1996; Patel et al., 1998; Lesage
et al., 2000; Murbartian et al., 2005; Deng et al., 2009; Xiao et al.,
2009), and both channels are expressed in the mouse midbrain
(Lein et al., 2007). Accordingly, we evaluated the impact of Trek
ablation on the motor-stimulatory and rewarding effect of mor-
phine, the prototypical mu opioid receptor agonist. Morphine
doses higher than 30mg/kg yielded elevated stereotypic move-
ments and reduced overall activity levels in wild-type mice
FIGURE 5 | Novel object recognition in mice lacking Trek channels.
Wild-type (WT, white), Trek2−/− (T2, gray), and Trek1/2/Traak−/−
(TTT, black) mice were evaluated in a novel object recognition task (n = 7–9
per group). No genotype-dependent differences were observed in terms of
the amount of time spent during a 5min (300 s) test session interacting
with the familiar object (A) [F(2, 22) = 1.7, P = 0.21], time spent interacting
with the novel object (B) [F(2, 22) = 1.0, P = 0.39], total time interacting
with the familiar and novel object (C) [F(2, 22) = 1.2, P = 0.31], or in object
discrimination ratio (D) [F(2, 22) = 0.1, P = 0.87], defined as the ratio of
time spent exploring the novel object to the total time spent exploring both
objects [timenovel/(timefamiliar + timenovel)].
(not shown), and thus, 30mg/kg morphine was selected as the
maximal dose in this study. No effect of gender was observed in
this task [F(1, 114) < 0.001, P = 0.98]; as such, data from male
and female subjects were pooled. Systemic morphine admin-
istration stimulated motor activity in a dose-dependent man-
ner in all genotypes (Figure 6A). While no difference between
genotypes was observed at the lowest morphine doses evalu-
ated (3 and 10mg/kg), Trek1/2/Traak−/− mice exhibited less
morphine-induced motor activity at the 30mg/kg dose.
Morphine-induced CPP was analyzed in wild-type, Trek2−/−
and Trek1/2/Traak−/− mice using a two-compartment chamber.
On Day 1, mice were allowed to explore both sides of the cham-
ber during a 15min session, and time spent on each side of
the chamber was recorded. Over the next 3 days, animals were
subjected to conditioning sessions where saline (AM session) or
FIGURE 6 | Opioid-induced motor activity and reward in mice lacking
Trek channels. (A) Morphine-induced locomotor activity was measured
during a 60min session in wild-type (WT, white), Trek2−/− (T2, gray), and
Trek1/2/Traak−/− (TTT, black) mice (n = 12–16 per group). Significant main
effects of morphine dose [F(3, 144) = 250.6, P < 0.0001] and genotype
[F(2, 144) = 4.6, P < 0.05] were observed, as well as a dose x genotype
interaction [F(6, 114) = 2.5, P < 0.05]. While no significant differences were
observed between genotypes at either the 3mg/kg or 10mg/kg doses,
Trek1/2/Traak−/− showed a slightly blunted response to 30mg/kg
morphine as compared to wild-type controls. (B) Morphine-induced CPP
was measured in wild-type (n = 10–15/dose), Trek2−/− (n = 7–9/dose), and
Trek1/2/Traak−/− (n = 6–7/dose) mice using a standard CPP test. While a
significant main effect of morphine dose was observed [F(2, 73) = 9.0,
P < 0.001], there was no main effect of genotype [F(2, 73) = 0.5, P = 0.59]
or dose x genotype interaction [F(4, 73) = 0.32, P = 0.86]. No
genotype-dependent differences were observed in morphine-induced CPP,
as measured by calculating the change in time spent ( time spent) in the
drug-paired side from Day 1–5. In panels A and B, only within-dose
pair-wise comparisons are highlighted. Symbols: ∗∗∗ P < 0.01, vs. wild-type.
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morphine (1, 3, or 10mg/kg; PM session) was administered sys-
temically prior to confinement in a defined (counterbalanced)
side of the chamber. In a pilot study involving wild-type mice,
no difference in the magnitude of the morphine-induced CPP
was observed for 10 and 30mg/kg morphine doses [t22 = 0.2,
P = 0.9]. Accordingly, wild-type and Trek−/− mice were chal-
lenged with 10mg/kgmorphine as the highest dose in this test. No
effect of gender was observed [F(1, 64) = 0.1, P = 0.81]; as such,
male and female data was pooled. A dose-dependent increase in
time spent in the drug-paired side was observed for all genotypes,
and the magnitude of the morphine-induced CPP measured
in Trek2−/− and Trek1/2/Traak−/− mice was no different from
wild-type controls at any dose tested (Figure 6B).
DISCUSSION
Recent work by our laboratory, as well as in situ hybridization
data collected by the Allen Institute for Brain Research (Lein
et al., 2007), suggests a widespread distribution of Trek2 mRNA
in the mouse CNS. Accordingly, and given the well-documented
and broad expression of Trek1 and Traak in the rodent CNS
(Medhurst et al., 2001; Talley et al., 2001; Gu et al., 2002), one
might predict that Trek channel activity influences neurophysi-
ology and behavior in a broad manner. The primary goal of this
study was to begin assessing the impact of Trek ablation onmouse
behavior, using a representative battery of behavioral paradigms.
Trek gene ablation exerted little influence on motor activity
or coordination. A significant difference, and clear interaction
between genotype and gender, was observed in anxiety-
related behavior in the open-field. Female Trek2−/− and
Trek1/2/Traak−/− mice exhibited significantly reduced thigmo-
taxis and increased time spent in the center of the open-field.
While many brain regions have been linked to anxiety, the hip-
pocampus and amygdala are key anatomic loci for anxiety-related
behavior (Menard and Treit, 1999; Canteras et al., 2010). In this
regard, the relatively high level of Trek2 mRNA observed in both
structures in the mouse and human may be relevant (Medhurst
et al., 2001; Lein et al., 2007; Mirkovic and Wickman, 2011).
However, Trek2−/− and Trek1/2/Traak−/− mice performed sim-
ilar to wild-type controls in the elevated plus maze and light/dark
box tests, other established tests of anxiety-related behavior. Such
discrepancies within anxiety-related behavioral paradigms have
been reported for other mutant mouse strains (Salas et al., 2003;
Bhatnagar et al., 2004; Lau et al., 2008), and argue that any
influence of Trek channels on anxiety-related behavior is modest
and/or not uniform.
Recent work has shown that Trek channels mediate, in part,
the inhibitory effect of GABAB receptor stimulation on neurons
in the hippocampus and entorhinal cortex (Deng et al., 2009;
Sandoz et al., 2012), and have suggested a role for Trek chan-
nels in learning and memory (Deng et al., 2009). We, however,
observed no influence of Trek ablation on learning and mem-
ory, as assessed using novel object recognition and contextual fear
conditioning tasks. One concern in studies involving these and
other standard paradigms is whether underlying abnormalities
in sensory perception influence behavioral outcomes. And while
our experience did not reveal gross deficiencies in vision, hearing,
or touch in Trek−/− mice, we cannot exclude the possibility that
subtle differences exist that impacted their performance in some
of the chosen tasks. For example, previous studies have revealed
decreased pain thresholds with Trek1−/− and Traak−/− mice
(Alloui et al., 2006; Noel et al., 2009). As such, the behavior
of Trek−/− mice in paradigms that involve an aversive stimu-
lus, such as a foot shock (e.g., contextual fear conditioning),
could reflect altered sensitivity to the aversive stimulus, altered
associative learning processes and/or memory recall, or a mix-
ture of influences. Nevertheless, the simplest interpretation of our
fear conditioning and novel object recognition data is that Trek
channels exert little if any significant influence over associative
learning processes.
Trek channels are activated by receptors linked to Gi/o G
proteins in a process thought to involve inhibition of cAMP pro-
duction and a decrease in PKA-dependent phosphorylation (Patel
et al., 1998; Lesage et al., 2000; Murbartian et al., 2005; Deng
et al., 2009; Xiao et al., 2009). Opioids such as morphine bind
to Gi/o coupled receptors expressed in the midbrain, leading
to increased motor activity and CPP (Bozarth and Wise, 1986;
Bozarth, 1987; Kalivas and Duffy, 1987; Latimer et al., 1987). As
Trek channels are expressed in the mouse midbrain (Lein et al.,
2007), we probed for a contribution of Trek channels to opioid-
induced reward-related behavior. Interestingly, Trek1/2/Traak−/−
mice did display a blunted motor-stimulatory response to the
highest dose of morphine tested. As Trek2−/− mice behaved nor-
mally in this task, the phenotype is most likely attributable to the
loss of Trek1, since Traak channels are not modulated by G pro-
tein signaling (Fink et al., 1998; Maingret et al., 2000; Kim et al.,
2001). In contrast, we found no impact of Trek channel ablation
on morphine-induced CPP. Thus, consistent with our assessment
of anxiety-related behavior in Trek−/− mice, any contribution of
Trek channels to opioid-induced reward-related behavior appear
to be modest and paradigm-dependent.
While the broad CNS distribution of Trek channels sug-
gests that this channel family makes significant contributions to
many behaviors, we found few neurobehavioral phenotypes in
Trek−/− mice in this study. An important consideration for any
study involving constitutive gene ablation is that subtle molecular
and/or developmental compensation might mask the influence of
a gene or genes on complex behaviors. Accordingly, data from
studies involving constitutive knockout mice should be inter-
preted with caution until corroborated by data obtained via alter-
native approaches. This is particularly true for studies such as this,
where the behavior ofmultiple congenicmutant lines is compared
to a single wild-type control group rather than to same-sex wild-
type littermates. Nevertheless, the simplest interpretation of the
available data is that the neurobehavioral influence of Trek chan-
nels is relatively modest or non-existent, at least in the context of
the behaviors evaluated in this study.
One intriguing scenario that might reconcile the broad CNS
distribution of Trek channels with their modest impact on behav-
ior is that Trek channel activity is low under normal conditions,
becoming evident and impactful only under certain circum-
stances, such as ischemia (Heurteaux et al., 2004; Buckler and
Honore, 2005; Caley et al., 2005; Wang et al., 2012). Indeed,
Trek channels are activated by polyunsaturated fatty acids (Patel
et al., 1998; Lesage et al., 2000; Maingret et al., 2000), intracellular
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acidification (Maingret et al., 1999; Lesage et al., 2000; Kim et al.,
2001), and membrane stretch (Patel et al., 1998; Bang et al., 2000;
Lesage et al., 2000), and all three of these influences are triggered
by cerebral ischemia. Moreover, Trek1−/− mice show enhanced
sensitivity to ischemia (Heurteaux et al., 2004), and Trek1 is
up-regulated after focal ischemia (Wang et al., 2012). Recently,
Trek2 expression was shown to increase after exposure to ischemic
conditions (Kucheryavykh et al., 2009). Thus, future studies
exploring the neurophysiological relevance of Trek2-containing
channels under ischemic conditions will be important.
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